TY - JOUR T1 - Phase I trial of DNA methyltransferase inhibitor guadecitabine combined with cisplatin and gemcitabine for solid malignancies including urothelial carcinoma (SPIRE) JO - Clinical Cancer Research UR - http://eprints.whiterose.ac.uk/172107/ PY - 2021/01/20 AU - Crabb SJ AU - Danson S AU - Catto JWF AU - Hussain S AU - Chan D AU - Dunkley D AU - Downs N AU - Marwood E AU - Day L AU - Saunders G AU - Light M et al ED - DO - DOI: 10.1158/1078-0432.ccr-20-3946 PB - American Association for Cancer Research (AACR) Y2 - 2025/04/11 ER -